Nelson memo

The Nelson Memo: Igniting a Global Open Data Revolution

The landscape of scientific research is undergoing a seismic shift, driven by an urgent demand for transparency, reproducibility, and equitable access. At the epicenter of this transformation in the United States is the Nelson Memo, a policy directive rapidly accelerating the future of open science. With the National Institutes of Health (NIH)'s recent announcement (NOT-OD-25-101)…...
Read More

Top Stories

MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Global Capability Centers

Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence

As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability...
NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025

The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,”...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical...

Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight

We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...
AI, ML, NLP, AR/VR, Blockchain in Healthcare

Emerging Technologies: Healthcare Communication Friend or Foe?

Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.